Skip to main content
logo
ORIC Pharmaceuticals logo
ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
11.31
-0.50 (-4.23%)
At close: Oct 13, 2026, 4:00 PM EDT
11.45
+0.14 (1.24%)
After-hours: Oct 13, 2026, 7:30 PM EDT

ORIC Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,172797569502265579
Market Cap Growth
-11.77%39.89%13.47%89.55%-54.26%-53.31%
Enterprise Value
91451730728584302
Last Close Price
11.818.188.079.205.8914.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.212.072.342.241.192.12
P/TBV Ratio
3.142.072.342.241.192.12

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.040.050.050.05
Net Debt / Equity Ratio
-0.68-0.71-1.01-0.88-0.87-0.82
Net Debt / EBITDA Ratio
1.671.931.741.802.262.88
Net Debt / FCF Ratio
2.312.452.172.292.523.71
Quick Ratio
12.7613.7910.3010.1813.4115.64
Current Ratio
13.1914.1310.5610.3913.6815.88
Return on Equity (ROE)
-39.80%-41.27%-54.73%-45.11%-35.98%-27.98%
Return on Assets (ROA)
-25.97%-26.17%-33.95%-27.74%-19.87%-16.50%
Return on Capital Employed (ROCE)
-40.70%-36.80%-57.30%-47.80%-37.40%-27.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.73%-16.25%-22.45%-20.06%-33.66%-13.60%
FCF Yield
-9.38%-14.02%-19.99%-17.24%-29.17%-10.45%
Buyback Yield / Dilution
-43.06%-25.91%-35.52%-29.74%-4.48%-72.97%
SEC Filings: 10-K · 10-Q